Key points are not available for this paper at this time.
PURPOSE: Despite its importance in ensuring sustainable healthcare, there are huge challenges with pharmaceutical research and development (R difficult procurement processes for R and the high cost of R&D. Availability of trainable human power and planned government incentives were identified as the opportunities. CONCLUSION: Overall, there is a low level of R&D capacity in local pharmaceutical industries and timely interventional strategies should be implemented through collaboration of academia, research institutions and pharmaceutical industries.
Selam et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: